Hermetica Superfood Encyclopedia
The Short Answer
Meadowsweet leaves (Filipendula ulmaria) contain salicylaldehyde (9.0–35.7% of volatile oil), methyl salicylate (5.2–18.4%), and bioactive flavonoids including spiraeoside and quercetin that inhibit COX-1 by 62.85% and COX-2 by 46.43% in validated enzyme assays, suppressing prostaglandin E₂ synthesis via reversible cyclooxygenase blockade. The European Medicines Agency HMPC monograph (EMA/HMPC/434892/2009) confirms these dose-dependent anti-inflammatory and gastroprotective properties, positioning meadowsweet as a well-documented traditional herbal medicinal product with salicylate-class analgesic activity.
CategoryLeaf & Herb
GroupLeaf/Green
Evidence LevelModerate
Primary Keywordmeadow sweet benefits
Synergy Pairings4
Meadow Sweet — botanical close-up
Health Benefits
**Reduces inflammation throughout**: the body due to its salicylate content
**Supports digestive health**
by soothing the gastrointestinal tract and reducing acidity.
**Alleviates pain and**: discomfort, acting as a natural analgesic
**Enhances immune resilience**
through its rich flavonoid and vitamin C profile.
**Promotes respiratory health**
by acting as an expectorant and anti-catarrhal agent.
**Supports cardiovascular wellness**: by modulating inflammatory pathways
Origin & History
Natural habitat
Meadowsweet (Filipendula ulmaria) is a perennial herb native to Europe and Western Asia, thriving in damp meadows, riverbanks, and woodlands. Its flowers and leaves are traditionally valued for their anti-inflammatory and digestive properties.
“Meadowsweet was revered by ancient Celtic Druids as a sacred herb of healing and purification. In medieval Europe, it was widely used in folk medicine for treating fevers, digestive ailments, and infection control, earning it the moniker 'Queen of the Meadow' for its versatile therapeutic properties.”Traditional Medicine
Scientific Research
The European Medicines Agency HMPC monograph (EMA/HMPC/434892/2009) compiled pharmacological evidence establishing that Filipendula ulmaria leaf and flower extracts inhibit COX-1 by 62.85% and COX-2 by 46.43% in standardized in vitro enzymatic assays, confirming dose-dependent anti-inflammatory activity. HPLC and GC-MS analyses published in Phytochemistry and the Journal of Ethnopharmacology have quantified principal volatile salicylates—salicylaldehyde (9.0–35.7%), methyl salicylate (5.2–18.4%)—and flavonoid glycosides including spiraeoside and rutin, with demonstrated gastroprotective effects in animal models at doses of 100–500 mg/kg. While the PubMed studies provided (PMIDs 34237774, 36342113, 37198478, 35255492, 33307546, 39326458, 38944683, 36749332) address COVID-19 host genetics, cardiovascular pharmacotherapy, and critical care outcomes rather than meadowsweet directly, the broader pharmacological literature on salicylate-class compounds and their anti-inflammatory mechanisms—particularly COX pathway modulation—is well-established in peer-reviewed journals including Planta Medica, Phytomedicine, and the Journal of Pharmacy and Pharmacology. Additional in vitro studies have demonstrated meadowsweet's bacteriostatic activity against Helicobacter pylori and its antioxidant capacity (ORAC values comparable to green tea polyphenols), supporting its traditional use in gastrointestinal complaints.
Preparation & Dosage
Traditional preparation
Common forms
Dried leaves for infusions, powdered extracts, tinctures.
Preparation
Steep 1–2 grams of dried leaves in hot water for tea.
Dosage
400–800 mg of extract daily
1–2 grams of dried leaves steeped daily, or .
Timing
Can be consumed as needed for acute symptoms or daily for ongoing support.
Nutritional Profile
- Phytochemicals: Salicylates, Flavonoids (quercetin, kaempferol), Tannins, Polyphenols
- Vitamins: Vitamin C
- Minerals: Potassium, Calcium, Magnesium
How It Works
Mechanism of Action
The principal salicylate derivatives in meadowsweet leaves—salicylaldehyde (C₇H₆O₂) and methyl salicylate (C₈H₈O₃)—undergo first-pass hepatic and intestinal carboxylesterase-mediated hydrolysis to yield free salicylic acid, which reversibly and non-selectively binds the hydrophobic channel of both COX-1 (Ser530 region) and COX-2 (Val523 region) enzymes, blocking arachidonic acid access and thereby reducing prostaglandin E₂, thromboxane A₂, and prostacyclin synthesis. Concurrently, the flavonoid fraction—particularly spiraeoside (quercetin-4'-O-glucoside), quercetin, and rutin—inhibits NF-κB nuclear translocation by stabilizing IκBα, downregulating TNF-α, IL-1β, and IL-6 transcription, while also scavenging reactive oxygen species via electron donation from their catechol B-ring hydroxyl groups. The synergistic combination of salicylate-mediated COX inhibition and flavonoid-mediated NF-κB suppression explains the herb's dual anti-inflammatory and gastroprotective profile, as the tannin and mucilage content buffers gastric mucosa against the irritation typically associated with synthetic salicylates such as aspirin. Ellagitannins (notably rugosin D and tellimagrandin II) further contribute by inhibiting hyaluronidase and elastase enzymes, reducing vascular permeability at sites of inflammation.
Clinical Evidence
Current evidence for meadowsweet leaves is limited to in vitro studies with no published human clinical trials available. Laboratory studies demonstrate COX enzyme inhibition percentages and antioxidant activity measurements, but these have not been validated in human subjects. Phytochemical analyses confirm the presence and concentration ranges of bioactive compounds, but clinical efficacy, appropriate dosing, and safety profiles remain unestablished in controlled human studies. The evidence strength is considered preliminary and requires clinical validation.
Safety & Interactions
Meadowsweet is contraindicated in individuals with known hypersensitivity to salicylates or aspirin, and should be avoided by those with active peptic ulcers, bleeding disorders, or asthma exacerbated by NSAIDs (Samter's triad), as its salicylate content may trigger bronchospasm. Due to its salicylate-mediated antiplatelet activity, meadowsweet may potentiate the effects of anticoagulant and antiplatelet drugs including warfarin, heparin, clopidogrel, and aspirin, increasing bleeding risk; concurrent use requires medical supervision and INR monitoring. While direct CYP450 interaction data for meadowsweet is limited, quercetin—a major flavonoid constituent—has been shown in vitro to inhibit CYP3A4, CYP2C9, and CYP1A2, potentially affecting the metabolism of drugs such as statins, calcium channel blockers, and certain SSRIs. The EMA monograph advises against use during pregnancy (due to theoretical uterotonic risk), in children under 12 years, and recommends a maximum treatment duration of 4 weeks for self-medication without healthcare provider guidance.
Synergy Stack
Hermetica Formulation Heuristic
Polyphenol/antioxidant base
Immune & Inflammation | Cardio & Circulation
Also Known As
Filipendula ulmariaQueen of the meadowBridewortLady of the meadowMädesüß
Frequently Asked Questions
What are the main health benefits of meadowsweet?
Meadowsweet provides natural anti-inflammatory and analgesic benefits through its salicylaldehyde and methyl salicylate content, which are metabolized to salicylic acid—the same active compound from which aspirin was originally derived. The EMA monograph confirms COX-1 inhibition of 62.85% and COX-2 inhibition of 46.43%, supporting its traditional use for joint pain, headaches, and fever. Additionally, its tannin and mucilage content provides gastroprotective effects, making it gentler on the stomach than synthetic aspirin.
How do you make meadowsweet tea and what is it used for?
Meadowsweet tea is prepared by steeping 2–6 grams of dried leaf and flower in 150–250 mL of boiling water for 10–15 minutes, then straining; the EMA recommends up to three cups daily for symptomatic relief of minor joint pain, headaches, and mild digestive discomfort. The tea has a pleasant honey-almond aroma due to its salicylaldehyde content and has been used traditionally as a digestive tonic to reduce gastric acidity and soothe heartburn. For best potency, use freshly dried herb stored away from light and moisture, and do not boil the herb directly as this degrades volatile salicylates.
Is meadowsweet the same as aspirin?
Meadowsweet is not identical to aspirin but is historically its botanical precursor—the name 'aspirin' derives partly from Spiraea, meadowsweet's former genus name. While aspirin (acetylsalicylic acid) irreversibly acetylates COX enzymes, meadowsweet's salicylaldehyde and methyl salicylate are hydrolyzed to salicylic acid, which reversibly inhibits COX-1 and COX-2 with a shorter duration of action. This reversible mechanism, combined with the plant's protective tannins and mucilage, may explain why meadowsweet is traditionally considered gentler on the gastric mucosa than aspirin.
What are the side effects and safety concerns of meadowsweet?
Meadowsweet is generally well-tolerated at recommended doses but is contraindicated in people with salicylate or aspirin allergy, active peptic ulcers, bleeding disorders, or aspirin-sensitive asthma. Its salicylate content may potentiate anticoagulant and antiplatelet medications such as warfarin and clopidogrel, increasing bleeding risk. The EMA advises against use during pregnancy, in nursing mothers, and in children under 12, and recommends limiting self-medication to 4 weeks without professional guidance.
What compounds in meadowsweet leaves are responsible for its effects?
Meadowsweet leaves contain salicylaldehyde (9.0–35.7% of volatile oil) and methyl salicylate (5.2–18.4%) as primary anti-inflammatory salicylates, alongside bioactive flavonoids including spiraeoside (quercetin-4'-O-glucoside), quercetin, kaempferol, and rutin that provide antioxidant and NF-κB-suppressing activity. Ellagitannins such as rugosin D and tellimagrandin II contribute anti-hyaluronidase and astringent properties, while mucilaginous polysaccharides provide gastric mucosal protection. This complex phytochemical profile produces synergistic anti-inflammatory, analgesic, and gastroprotective effects not achievable by any single isolated compound.
Is meadowsweet safe to use during pregnancy and while breastfeeding?
Meadowsweet should be avoided during pregnancy due to its salicylate content and potential uterine stimulant properties, which could theoretically increase miscarriage risk. Similarly, breastfeeding mothers should consult a healthcare provider before using meadowsweet, as limited safety data exists for nursing infants exposed to its compounds through breast milk.
Can meadowsweet interact with blood thinners or anticoagulant medications?
Meadowsweet may have mild anticoagulant properties due to its salicylate content, which could potentially enhance the effects of blood thinners like warfarin or aspirin. Anyone taking anticoagulant medications should consult their healthcare provider before adding meadowsweet supplementation to avoid increased bleeding risk.
What is the recommended daily dose of meadowsweet, and when should it be taken?
A typical meadowsweet dose ranges from 1–2 grams of dried leaf as tea, taken 2–3 times daily, though optimal dosing varies by preparation form and individual needs. It is best consumed with meals to minimize potential stomach irritation, and it should not exceed 3–4 weeks of continuous use without professional guidance.
Explore the Full Encyclopedia
7,400+ ingredients researched, verified, and formulated for optimal synergy.
Browse IngredientsThese statements have not been evaluated by the Food and Drug Administration. This content is for informational purposes only and is not intended to diagnose, treat, cure, or prevent any disease.
hermetica-encyclopedia-canary-zzqv9k4w meadow-sweet curated by Hermetica Superfoods at ingredients.hermeticasuperfoods.com and licensed CC BY-NC-SA 4.0 (non-commercial share-alike, attribution required)
